Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

Completed · Phase 4

Conditions studied: Basal Cell Carcinoma

In brief

A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.

Key facts

Study ID

NCT00581425

Run by

The University of Texas Health Science Center, Houston

People needed

49

Starts

2007-12-01

Expected to finish

2011-09-01

Last updated by the study team

2013-01-25

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Nodular or superficial basal cell carcinoma on the skin excluding scalp or face

You may not qualify if…

• Pregnancy

Where it is running

• University of Texas Health Science Center of Houston Dermatology Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.